Update on triple-negative breast cancers - highlighting subtyping update and treatment implication

Area of Science:

• Oncology
• Genomics
• Immunology

Background:

• Triple-negative breast cancer (TNBC) presents significant management challenges.
• TNBC is characterized by substantial heterogeneity in histology, molecular, and immunological profiles.
• Existing research highlights diverse clinical presentations and biological behaviors within TNBC.

Purpose of the Study:

• To provide an overview of recent findings on TNBC heterogeneity.
• To discuss the classification of TNBC into distinct subtypes.
• To explore the implications of TNBC subtyping for therapeutic strategies and prognostication.

Main Methods:

• Review of current scientific literature on TNBC heterogeneity and subtyping.
• Analysis of gene expression profiling studies to identify predominant TNBC subtypes.
• Examination of genomic alterations and tumor microenvironment characteristics associated with each subtype.

Main Results:

• TNBC exhibits significant heterogeneity, with at least four predominant subtypes identified based on expression profiling.
• These subtypes display distinct genomic alterations and tumor microenvironment compositions.
• Subtype-specific therapeutic strategies have been identified, correlating with improved prognostication.

Conclusions:

• Recognizing TNBC subtypes is crucial for improved prognostication.
• TNBC subtyping facilitates more informed and personalized treatment decisions.
• Understanding heterogeneity is key to developing more effective therapeutic options for triple-negative breast cancer.